CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 8-K Event Shareholder vote results
- 4 Open-market buy Chief Executive Officer bought 2,183 shares at $2.28 ($4,970)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $2.50 ($6,250)
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 3,000 shares at $2.42 ($7,260)
- S-1 Offering Registration Statement
- 10-K/A Report 10-K/A
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 18 of 74 · 1,465 filings